Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...

The bills, which have advanced in the Senate, would require schools to take certain preventative measures to protect student ...

Two new class action complaints, both captioned Robins v. Lemme Inc., were filed in in California Superior Court and the Southern District of New ...

Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes ...

In 24 of the 27 attacks, complete recovery occurred five to thirty minutes after a single intramuscular injection of 1 mg. of glucagon. In the remaining 3 attacks (all in the same patient), there ...

The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...

Most other obesity treatments work only on GLP-1, or on GLP-1 plus glucagon. Retatrutide acts in three ways to promote weight loss. Retatrutide is given as a shot under the skin once a week.

Serious hypersensitivity reactions have been reported with glucagon, including generalized ... once-weekly subcutaneous injection for hypothyroidism, as well as multiple early-stage programs ...